Peptides for stimulating an immune response against melanoma
US7887822B2 · kind B2 · utility
11Cited by
1References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 17, 2006 |
| Grant date | Feb 15, 2011 |
| Priority date | — |
| Expiry date | Dec 1, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided in the present invention are recombinant peptides and a method for using the peptides in stimulating an immune response against human high molecular weight-melanoma associated antigen (HMW-MAA). The peptides were designed from the identification of regions of structural and amino acid sequence homology between HMW-MAA and the mouse anti-idiotypic monoclonal antibody MK2-23. The method comprises the step of administering to an individual a peptide of the invention in an amount effective to elicit an immune response against HMW-MAA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.